Invesco
APEN

Invesco’s Apollo Endosurgery, Inc. APEN Stock Holding History

Invesco’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-311,028
Closed -$1.88M – 4196
2022
Q1 		$1.88M Buy
+311,028
New +$1.9M ﹤0.01% 2806
2021
Q4 		– Sell
-294,649
Closed -$2.67M – 4126
2021
Q3 		$2.67M Buy
+294,649
New +$2.53M ﹤0.01% 2684
2021
Q2 		– Sell
-10,477
Closed -$58K – 4070
2021
Q1 		$58K Buy
+10,477
New +$51.8K ﹤0.01% 3823

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Invesco's APEN Position: Q2 2022 in Review

Invesco sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2022, closing a stake of 311,028 shares — an estimated $1.88M sold.

Invesco first reported a position in APEN in Q1 2021 and held it in 3 quarters. The position peaked at $2.67M in Q3 2021. 63 funds tracked by Wall St. Rank hold APEN as of Q2 2022.

  • Invesco reported no remaining Apollo Endosurgery, Inc. position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 311,028 Apollo Endosurgery, Inc. shares in Q2 2022, an estimated $1.88M.
  • Invesco first reported a position in Apollo Endosurgery, Inc. in Q1 2021 and held it in 3 quarters.
  • Invesco's Apollo Endosurgery, Inc. position peaked at $2.67M in Q3 2021.
  • 63 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.